In the pharmaceutical industry, the quality of raw materials and intermediates is directly correlated with the safety and efficacy of the final drug product. For 4-(2-Aminoethyl)benzenesulfonamide (CAS: 35303-76-5), a crucial intermediate in the synthesis of antidiabetic drugs like Glipizide, stringent quality control and adherence to precise specifications are non-negotiable. This article outlines the key quality parameters that pharmaceutical manufacturers and R&D scientists should look for when sourcing this vital compound from suppliers.

The Importance of High Purity

The primary specification for 4-(2-Aminoethyl)benzenesulfonamide intended for pharmaceutical use is its purity. Typically, manufacturers guarantee a purity level of ≥98.5% as determined by High-Performance Liquid Chromatography (HPLC). This high purity ensures that the intermediate does not introduce unwanted byproducts or impurities into the final API, which could compromise its therapeutic effectiveness or patient safety. A supplier's ability to consistently achieve and verify this purity level is a critical indicator of their manufacturing expertise and quality management systems.

Key Quality Control Parameters

Beyond overall purity, several other quality control parameters are essential for validating 4-(2-Aminoethyl)benzenesulfonamide:

• Loss on Drying (LOD): This measures the amount of volatile matter (primarily water or residual solvents) present in the sample. For 4-(2-Aminoethyl)benzenesulfonamide, a low LOD, typically ≤0.5%, is desirable to ensure product stability and accurate weighing during synthesis.
• Residue on Ignition (ROI): Also known as sulfated ash, this test indicates the level of inorganic impurities. A low ROI, often ≤0.12%, is crucial for pharmaceutical intermediates to prevent contamination with inorganic salts or metals.
• Related Substances/Impurities: Specific limits are set for known impurities, including any related structural isomers or byproducts from the synthesis. For example, limits for 'acetylated side chain' and 'other single impurity' are often specified, along with a 'total impurities' limit. Adhering to these specific impurity profiles is vital.
• Melting Point: The melting point range (e.g., 146-153°C) serves as a physical characteristic to confirm the identity and purity of the compound. Deviations from the expected range can indicate the presence of impurities.

Documentation and Compliance: The Certificate of Analysis (CoA)

A comprehensive Certificate of Analysis (CoA) is the cornerstone of quality assurance for any pharmaceutical intermediate. A reputable manufacturer will provide a batch-specific CoA that details all the tested parameters against their established standards. This document should include:

• Product name and CAS number
• Batch number
• Test methods used (e.g., HPLC for assay)
• Specification limits for each parameter
• Actual test results for the specific batch
• Release date and expiry/retest date
• Signature of authorized quality control personnel

For cGMP-compliant applications, ensuring the manufacturer's CoA meets regulatory expectations is paramount. When you buy 4-(2-Aminoethyl)benzenesulfonamide, always scrutinize the CoA.

Supplier Selection Considerations

When sourcing 4-(2-Aminoethyl)benzenesulfonamide, pharmaceutical companies should partner with manufacturers who:

• Demonstrate Robust Quality Systems: Look for ISO certifications and a strong commitment to quality management.
• Offer Traceability: Ensure full traceability from raw materials to the final product.
• Provide Technical Support: Responsive technical teams can assist with formulation or synthesis challenges.
• Maintain Consistent Supply: A reliable supply chain is critical for production continuity.

By understanding and prioritizing these quality control measures and specifications, pharmaceutical companies can confidently source 4-(2-Aminoethyl)benzenesulfonamide, ensuring the integrity and efficacy of their final drug products. Engaging with experienced manufacturers, especially those in China, can provide access to high-quality materials that meet the demanding standards of the pharmaceutical industry.